These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 19455605)
1. Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival. Johansson M; McKay JD; Rinaldi S; Wiklund F; Adami HO; Grönberg H; Kaaks R; Stattin P Prostate; 2009 Sep; 69(12):1281-91. PubMed ID: 19455605 [TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk. Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539 [TBL] [Abstract][Full Text] [Related]
3. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136 [TBL] [Abstract][Full Text] [Related]
4. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study. Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263 [TBL] [Abstract][Full Text] [Related]
5. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families. Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206 [TBL] [Abstract][Full Text] [Related]
6. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA. Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer. Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946 [TBL] [Abstract][Full Text] [Related]
8. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men. Park K; Kim JH; Jeon HG; Byun SS; Lee E Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746 [TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age. van der Kaay DC; Hendriks AE; Ester WA; Leunissen RW; Willemsen RH; de Kort SW; Paquette JR; Hokken-Koelega AC; Deal CL Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499 [TBL] [Abstract][Full Text] [Related]
10. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese. Wong HL; Delellis K; Probst-Hensch N; Koh WP; Van Den Berg D; Lee HP; Yu MC; Ingles SA Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):144-51. PubMed ID: 15668488 [TBL] [Abstract][Full Text] [Related]
11. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor. Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371 [TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Diorio C; Brisson J; Bérubé S; Pollak M Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029 [TBL] [Abstract][Full Text] [Related]
13. Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction. Murisier-Petetin G; Gremlich S; Damnon F; Reymondin D; Hohlfeld P; Gerber S Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):15-20. PubMed ID: 19217707 [TBL] [Abstract][Full Text] [Related]
14. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I. Chu LW; Zhu Y; Yu K; Zheng T; Chokkalingam AP; Stanczyk FZ; Gao YT; Hsing AW Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3268-73. PubMed ID: 18990770 [TBL] [Abstract][Full Text] [Related]
15. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development. Lindström S; Wiklund F; Adami HO; Bälter KA; Adolfsson J; Grönberg H Cancer Res; 2006 Nov; 66(22):11077-83. PubMed ID: 17108148 [TBL] [Abstract][Full Text] [Related]
16. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men. Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534 [TBL] [Abstract][Full Text] [Related]
17. Influence of MUC1 genetic variation on prostate cancer risk and survival. Strawbridge RJ; Nister M; Brismar K; Li C; Lindström S Eur J Hum Genet; 2008 Dec; 16(12):1521-5. PubMed ID: 18628787 [TBL] [Abstract][Full Text] [Related]
18. Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival. Hayes VM; Severi G; Southey MC; Padilla EJ; English DR; Hopper JL; Giles GG; Sutherland RL Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1223-5. PubMed ID: 16775185 [TBL] [Abstract][Full Text] [Related]
19. Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk. Feik E; Baierl A; Hieger B; Führlinger G; Pentz A; Stättner S; Weiss W; Pulgram T; Leeb G; Mach K; Micksche M; Gsur A Cancer Causes Control; 2010 Jan; 21(1):91-7. PubMed ID: 19784788 [TBL] [Abstract][Full Text] [Related]
20. Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk. McKay JD; Kaaks R; Johansson M; Biessy C; Wiklund F; Bälter K; Adami HO; Boillot C; Gioia-Patricola L; Canzian F; Stattin P; Grönberg H Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):169-73. PubMed ID: 17220348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]